2. Costs and cost‐effectiveness.
Author (year) | Georgiou (2001) |
HF‐ACTION Reed (2010) |
Witham (2012) | Cowie (2014) Centre and home | Dalal (2018) | Lang (2018) |
Year of costs Country Currency |
1998 US USD |
2008 US USD |
2010 UK GBP |
2013/2014 UK GBP |
2016 UK GBP |
2016 UK GBP |
Intervention cost | ||||||
Mean costs/patient | 4,563 | 6,483 (SD 4,884) | 474.75 | Not reported | 418.39 | 362.61 |
Costs considered | Staffing, space rental, equipment, patients’ lost wages | Staffing, patient time, travel, parking | Staffing, equipment, staff and patient travel | Staffing, equipment, consumables* (*home training only) |
Primary and secondary care, social care, drugs, NHS and intervention costs | Staffing, equipment, staff travel |
Cost‐effectiveness | ||||||
Follow‐up period | 15.5 years | Mean 2.5 years | 6 months | 5 years | NR | NR |
Total mean healthcare cost/patient (exercise) |
5,282* | 57,338 (SD 81,343)+ | 1888.24 (SD 3111) | 221.58 (hospital) and 196.53 (home) | NR | NR |
Total mean healthcare costs per patient (control) |
2,055* | 56,177 (SD 92,749)+ | 1943.93 (SD 4551) | Not calculated | NR | NR |
Incremental healthcare costs | 3227* | 1,161 (95% CI ‐6,205 to 8,404) | ‐447.85 (95% CI ‐1696.00 to 931.00) | NR | NR | NR |
Additional healthcare costs considered |
Hospitalisations | Medication, procedures, outpatient visits, emergency visits, hospitalisations, tests | Inpatient and outpatient admissions, primary care contacts, medication | NR | NR | NR |
Mean healthcare benefit (exercise) | 10.24 life‐years | 2.02 QALYs (SD 1.00) | NR | NR | 0.74 QALYs (SD 0.22) | NR |
Mean health care benefit (control) | 7.96 life‐years | 1.99 QALYs (SD 1.01) | NR | NR | 0.76 QALYs (SD 0.21) | NR |
Incremental mean healthcare benefit | 1.82 life‐years | 0.03 (95% CI ‐0.06 to 0.11) | NR | NR | NR | NR |
Incremental cost‐effectiveness ratio | 1,773 per life‐year saved | NR | NR | NR | NR | NR |
CI: confidence interval; GBP: GB pounds; NR: not reported; QALY: quality‐adjusted life year; SD: standard deviation; USD: US dollars.